Melanocortin-4 Receptor PLC Activation Is Modulated by an Interaction with the Monocarboxylate Transporter 8

The melanocortin-4 receptor (MC4R) is a key player in the hypothalamic leptin–melanocortin pathway that regulates satiety and hunger. MC4R belongs to the G protein-coupled receptors (GPCRs), which are known to form heterodimers with other membrane proteins, potentially modulating receptor function or characteristics. Like MC4R, thyroid hormones (TH) are also essential for energy homeostasis control. TH transport across membranes is facilitated by the monocarboxylate transporter 8 (MCT8), which is also known to form heterodimers with GPCRs. Based on the finding in single-cell RNA-sequencing data that both proteins are simultaneously expressed in hypothalamic neurons, we investigated a putative interplay between MC4R and MCT8. We developed a novel staining protocol utilizing a fluorophore-labeled MC4R ligand and demonstrated a co-localization of MC4R and MCT8 in human brain tissue. Using in vitro assays such as BRET, IP1, and cAMP determination, we found that MCT8 modulates MC4R-mediated phospholipase C activation but not cAMP formation via a direct interaction, an effect that does not require a functional MCT8 as it was not altered by a specific MCT8 inhibitor. This suggests an extended functional spectrum of MCT8 as a GPCR signaling modulator and argues for the investigation of further GPCR-protein interactions with hitherto underrepresented physiological functions.

[1]  Bradley Carlson,et al.  A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice , 2024, The Journal of clinical investigation.

[2]  Sidney M. Bell,et al.  CZ CELL×GENE Discover: A single-cell data platform for scalable exploration, analysis and modeling of aggregated data , 2023, bioRxiv.

[3]  R. H. Costa-e-Sousa,et al.  Regulation of thyroid hormone levels by hypothalamic TRH (thyrotropin-releasing hormone) neurons. , 2023, Thyroid : official journal of the American Thyroid Association.

[4]  Trygve E Bakken,et al.  Transcriptomic diversity of cell types across the adult human brain , 2022, bioRxiv.

[5]  H. Biebermann,et al.  A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation , 2022, Biomolecules.

[6]  C. Vassalle,et al.  Main Factors Involved in Thyroid Hormone Action , 2021, Molecules.

[7]  Philipp Wolf,et al.  The ring size of monocyclic ET‐1 controls selectivity and signaling efficiency at both endothelin receptor subtypes , 2021, Journal of peptide science : an official publication of the European Peptide Society.

[8]  B. Kobilka,et al.  Structures of active melanocortin-4 receptor–Gs-protein complexes with NDP-α-MSH and setmelanotide , 2021, Cell Research.

[9]  Jong-Woo Sohn,et al.  Neuroendocrine control of appetite and metabolism , 2021, Experimental & Molecular Medicine.

[10]  E. Bertini,et al.  Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. , 2020, The lancet. Diabetes & endocrinology.

[11]  I. Bechmann,et al.  Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression. , 2020, Thyroid : official journal of the American Thyroid Association.

[12]  M. Lohse,et al.  Differential Signaling Profiles of MC4R Mutations with Three Different Ligands , 2020, International journal of molecular sciences.

[13]  R. Peeters,et al.  Thyroid hormone transporters. , 2019, Endocrine reviews.

[14]  T. Visser,et al.  In vitro characterization of human, mouse and zebrafish MCT8 orthologues. , 2019, Thyroid : official journal of the American Thyroid Association.

[15]  H. Biebermann,et al.  Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective , 2019, Front. Endocrinol..

[16]  H. Biebermann,et al.  Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment. , 2019, Trends in molecular medicine.

[17]  M. J,et al.  MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency , 2018, Nature Medicine.

[18]  Jong-Woo Sohn,et al.  Understanding melanocortin-4 receptor control of neuronal circuits: Toward novel therapeutics for obesity syndrome. , 2018, Pharmacological research.

[19]  Catherine L. Worth,et al.  Evidence of G-protein-coupled receptor and substrate transporter heteromerization at a single molecule level , 2017, Cellular and Molecular Life Sciences.

[20]  T. Visser,et al.  Outward‐Open Model of Thyroid Hormone Transporter Monocarboxylate Transporter 8 Provides Novel Structural and Functional Insights , 2017, Endocrinology.

[21]  J. Hebebrand,et al.  Decreased melanocortin‐4 receptor function conferred by an infrequent variant at the human melanocortin receptor accessory protein 2 gene , 2016, Obesity.

[22]  M. Tschöp,et al.  Ring Finger Protein 11 Inhibits Melanocortin 3 and 4 Receptor Signaling , 2016, Front. Endocrinol..

[23]  H. Biebermann,et al.  Oligomerization of GPCRs involved in endocrine regulation. , 2016, Journal of molecular endocrinology.

[24]  L. Schomburg,et al.  Silychristin, a Flavonolignan Derived From the Milk Thistle, Is a Potent Inhibitor of the Thyroid Hormone Transporter MCT8. , 2016, Endocrinology.

[25]  C. Holze,et al.  Fluorescently labeled adrenomedullin allows real‐time monitoring of adrenomedullin receptor trafficking in living cells , 2015, Journal of peptide science : an official publication of the European Peptide Society.

[26]  O. Gavrilova,et al.  G(q/11)α and G(s)α mediate distinct physiological responses to central melanocortins. , 2015, The Journal of clinical investigation.

[27]  A. Grüters,et al.  Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations. , 2014, Journal of molecular endocrinology.

[28]  J. Simpson,et al.  The trials and tubule-ations of Rab6 involvement in Golgi-to-ER retrograde transport. , 2014, Biochemical Society transactions.

[29]  J. Franklyn,et al.  MCT8 expression in human fetal cerebral cortex is reduced in severe intrauterine growth restriction , 2013, The Journal of endocrinology.

[30]  A. Grüters,et al.  Inhibition of melanocortin-4 receptor dimerization by substitutions in intracellular loop 2. , 2013, Journal of molecular endocrinology.

[31]  J. Nevzorova,et al.  β2‐Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C‐terminal tail , 2012, British journal of pharmacology.

[32]  M. Tschöp,et al.  MC4R Dimerization in the Paraventricular Nucleus and GHSR/MC3R Heterodimerization in the Arcuate Nucleus: Is There Relevance for Body Weight Regulation? , 2012, Neuroendocrinology.

[33]  A. Hollenberg,et al.  NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. , 2011, Cell metabolism.

[34]  T. Schöneberg,et al.  Mutually Opposite Signal Modulation by Hypothalamic Heterodimerization of Ghrelin and Melanocortin-3 Receptors* , 2011, The Journal of Biological Chemistry.

[35]  M. Gershengorn,et al.  Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Y. Tao The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. , 2010, Endocrine reviews.

[37]  W. Klootwijk,et al.  Evidence for a homodimeric structure of human monocarboxylate transporter 8. , 2009, Endocrinology.

[38]  T. Gudermann,et al.  Pertussis Toxin-sensitive Signaling of Melanocortin-4 Receptors in Hypothalamic GT1-7 Cells Defines Agouti-related Protein as a Biased Agonist* , 2009, The Journal of Biological Chemistry.

[39]  A. Grüters,et al.  Heterodimerization of Hypothalamic G-Protein-Coupled Receptors Involved in Weight Regulation , 2009, Obesity Facts.

[40]  S. Westmoreland,et al.  Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes , 2008, Journal of Pharmacology and Experimental Therapeutics.

[41]  C. Hoogenraad,et al.  A role for the Rab6B Bicaudal-D1 interaction in retrograde transport in neuronal cells. , 2007, Experimental cell research.

[42]  M. Mulholland,et al.  Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons. , 2006, The Journal of surgical research.

[43]  J. Dumont,et al.  Thyrotropin stimulates the generation of inositol 1,4,5-trisphosphate in human thyroid cells. , 2006, The Journal of clinical endocrinology and metabolism.

[44]  R. Maki,et al.  Dimerization of the melanocortin 4 receptor: A study using bioluminescence resonance energy transfer , 2006, Peptides.

[45]  A. Grüters,et al.  MC4R oligomerizes independently of extracellular cysteine residues , 2006, Peptides.

[46]  H. Biebermann,et al.  Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. , 2005, European journal of endocrinology.

[47]  Barbara Imperiali,et al.  Protein oligomerization: how and why. , 2005, Bioorganic & medicinal chemistry.

[48]  E. Fliers,et al.  Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. , 2005, The Journal of clinical endocrinology and metabolism.

[49]  R. Petrovska,et al.  Melanocortin receptors form constitutive homo- and heterodimers. , 2005, Biochemical and biophysical research communications.

[50]  A. Uitterlinden,et al.  Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation , 2004, The Lancet.

[51]  Michel Bouvier,et al.  Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Mei Bai,et al.  Dimerization of G-protein-coupled receptors: roles in signal transduction. , 2004, Cellular signalling.

[53]  T. Gudermann,et al.  Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. , 2003, Diabetes.

[54]  J. Kamegai,et al.  Hypothalamic Neuropeptide Y/Y1 Receptor Pathway Activated by a Reduction in Circulating Leptin, but Not by an Increase in Circulating Ghrelin, Contributes to Hyperphagia Associated with Triiodothyronine-Induced Thyrotoxicosis , 2003, Neuroendocrinology.

[55]  T. Visser,et al.  Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone Transporter* , 2003, Journal of Biological Chemistry.

[56]  M. Schwartz,et al.  The NPY/AgRP neuron and energy homeostasis , 2001, International Journal of Obesity.

[57]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[58]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  H. Lother,et al.  AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.

[60]  G. Schultz,et al.  The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[61]  H. Willard,et al.  A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. , 1994, Human molecular genetics.

[62]  S. Watson,et al.  Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.

[63]  J. Flier,et al.  Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. , 2001, The Journal of clinical investigation.